Tricals - The highway towards a cure

Trial overview

Clinical trials are needed to find a cure for ALS. TRICALS supports multiple clinical trials. View the clinical trial overview to see current and past trials.

Results

Archived

TUDCA-ALS

Phase 3
IIT
No

This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.

More about this trial

Archived

PHOENIX

Phase 3
Industry
No

Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035'.

More about this trial

Archived

CardinALS

Phase 2
Industry
No

The CARDINALS clinical research study is evaluating a study drug (Utreloxastat) to see if it can help slow ALS symptoms.

More about this trial

Archived

VRG50635 trial

Phase 1
Industry
No

Verge Genomics is conducting a phase 1b trial to evaluate the safety, tolerability, and potential efficacy of VRG50635.

More about this trial

Archived

ADORE

Phase 3
Industry
No

Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of FNP122 for people with ALS.

More about this trial

Archived

Lighthouse 2

Phase 3
IIT
No

The Lighthouse 2 study is a phase 3 clinical trial in which we will investigate the efficacy of the drug Triumeq.

More about this trial

Do you have questions about clinical trials?

Archived

VALOR

Phase 3
Industry
SOD1

Biogen is conducting a clinical trial to evaluate the safety and potential efficacy of an investigational drug for people with ALS.

More about this trial

Archived

RT001 trial

Phase 2
Industry
No

In this phase 2 trial, we will study the safety and efficacy of the compound RT001 in people living with ALS.

More about this trial

Archived

ALSpire

Phase 1
Industry
No

This phase 1 clinical trial is evaluating the safety, tolerability & pharmacokinetics of the drug ‘BIIB105’ in people living with ALS.

More about this trial

Archived

APL2-ALS-206 trial

Phase 2
Industry
No

In this phase 2 study, we are investigating the safety and efficacy of the drug pegcetacoplan for the treatment of ALS.

More about this trial

Archived

COURAGE-ALS

Phase 3
Industry
No

In the COURAGE-ALS study, we are investigating the efficacy and safety of the drug ‘reldesemtiv’ for the treatment of ALS.

More about this trial
Previous page123Next page
The TRICALS Registry

Register as a patient

Want to be notified by new clinical trials in your country? Register in the TRICALS registry and help us to get more people with ALS into a clinical trials.

Register